Inhibition of nuclear factor kappaB by sulfasalazine: a new target for inflammatory bowel disease therapy?

L. J. Egan; W. J. Sandborn

doi:10.1016/S0016-5085(98)70106-4

Inhibition of nuclear factor kappaB by sulfasalazine: a new target for inflammatory bowel disease therapy?

L. J. Egan, W. J. Sandborn

Pharmacology

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

12 Citations (Scopus)

Original language	English
Pages (from-to)	1295-1296
Number of pages	2
Journal	Gastroenterology
Volume	115
Issue number	5
DOIs	https://doi.org/10.1016/S0016-5085(98)70106-4
Publication status	Published - Nov 1998

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0016-5085(98)70106-4

Cite this

@article{1fc8896f3465426f8eeb7a17bf9beef1,

title = "Inhibition of nuclear factor kappaB by sulfasalazine: a new target for inflammatory bowel disease therapy?",

author = "Egan, \{L. J.\} and Sandborn, \{W. J.\}",

year = "1998",

month = nov,

doi = "10.1016/S0016-5085(98)70106-4",

language = "English",

volume = "115",

pages = "1295--1296",

journal = "Gastroenterology",

issn = "0016-5085",

publisher = "W.B. Saunders",

number = "5",

}

TY - JOUR

T1 - Inhibition of nuclear factor kappaB by sulfasalazine

T2 - a new target for inflammatory bowel disease therapy?

AU - Egan, L. J.

AU - Sandborn, W. J.

PY - 1998/11

Y1 - 1998/11

UR - http://www.scopus.com/inward/record.url?scp=0032209732&partnerID=8YFLogxK

U2 - 10.1016/S0016-5085(98)70106-4

DO - 10.1016/S0016-5085(98)70106-4

M3 - Article

C2 - 9797390

AN - SCOPUS:0032209732

SN - 0016-5085

VL - 115

SP - 1295

EP - 1296

JO - Gastroenterology

JF - Gastroenterology

IS - 5

ER -

Inhibition of nuclear factor kappaB by sulfasalazine: a new target for inflammatory bowel disease therapy?

UN SDGs

Access to Document

Other files and links

Cite this